Pharmaceutical research and development (R&D) in cardiovascular diseases is hibernating. This research collaboration between the ÐÓ°ÉÂÛ̳ and UCL will tackle high failure rates in R&D in cardiovascular disease. It will evaluate the economic, regulatory, and health system factors driving drug development in cardiovascular disease.
In addition to the research, UCLH staff and ÐÓ°ÉÂÛ̳ faculty and researchers will also jointly convene stakeholder events to increase impact and dissemination.